Integrative Medicine
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
What’s Best for the Breast?
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way. -
Pharmacology Update: Bevacizumab Injection (Avastin)
The FDA has approved the first antineoplastic that acts by the inhibiting the formation of new blood vessels in tumors. -
Clinical Briefs
Migraine and Subclinical Brain Lesions; Memantine Treatment in Alzheimer Disease; PPG in Type 2 DM -
Another Tool for a Common Problem
Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis. -
Full February 15, 2004, Issue in PDF
-
Pharmacology Update: Olanzapine and Fluoxetine Capsules (Symbyax — Lilly)
The FDA has approved a combination of olanzapine and fluoxetine for the treatment of depressive episodes associated with bipolar disorder. -
Clinical Briefs
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera; Coronary Artery Calcium Score Plus Framingham Score for Risk Prediction; Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis -
Ironing Out the Risk Factors for Diabetes
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women. -
Overview of Newer Antiepileptic Drugs for Neuropathic Pain and Migraine
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized.